Contact
    Start Publications De novo designed self-assembling helicomimetic ...
    ←  Publication Finder
    KSV NIMA

    De novo designed self-assembling helicomimetic lipooligoureas with antibacterial activity

    Year: 2023

    Journal: European Journal of Medicinal Chemistry, Volume 259, 05/11/2023, page 115700

    Authors: Bachurska-Szpala, Paulina; Burdach, Kinga; Lasek, Robert; Tymecka, Dagmara; Juhaniewicz-Dębińska, Joanna; Bartosik, Dariusz; Pułka-Ziach, Karolina; Sęk, Sławomir

    Keywords: Antimicrobial compounds; Oligourea; Peptidomimetic foldamers

    The overuse of antibiotics has led to a rise in infections caused by multidrug-resistant bacteria, resulting in a need for new antibacterial compounds with different modes of action. In this paper, we describe a new class of compounds called lipooligoureas, which are foldamer-based mimetics of antimicrobial lipopeptides. The lipooligoureas consist of an acyl chain connected to the N-terminus of an oligourea head group that exhibits a well-defined 2.5-helix secondary structure, which is further stabilized by the attachment of the lipophilic chain to the oligourea moiety. These compounds meet the established criteria for membranolytic compounds by possessing an amphiphilic structure that promotes the internalization and partitioning of the molecules into the lipid membrane. The presence of positively charged urea residues promotes electrostatic interactions with the negatively charged bacterial membrane. The subtle structural differences in oligourea head group influence the compounds' aggregation behavior, with the number and position of positively charged urea residues correlating with their aggregation ability. The biological activity of these compounds in inhibiting bacterial growth is correlated with their ability to aggregate, with stronger antibacterial properties exhibited by those that aggregate more easily. However, the concentration inhibiting bacterial growth is significantly lower than the critical aggregation concentration values, suggesting that the mechanism of action involves the monomeric forms of lipooligoureas. Nonetheless, a mechanism based on membrane-induced aggregation cannot be ruled out. The lipooligoureas exhibit higher activity towards Gram-positive bacteria than against Gram-negative bacteria, which is indicative of certain selectivity of these compounds. It is also demonstrated that lipooligoureas exhibit increased stability against proteolytic degradation in human blood serum.
    View publication